Benjamin A Steinberg

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. pmc Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
    Benjamin A Steinberg
    From the Duke University Medical Center, Durham, NC B A S, E D P, M W S, J P P Duke Clinical Research Institute, Durham, NC B A S, E D P, S K, L T, M W S, J P P Mayo Clinic, Rochester, MN B J G UCLA Division of Cardiology, Los Angeles, CA G C F Lankenau Institute for Medical Research, Wynnewood, PA P R K Department of Medicine, Stanford University School of Medicine, Palo Alto, CA K W M Janssen Scientific Affairs, Raritan, NJ P C and New York University School of Medicine, Lenox Hill Hospital, New York, NY J A
    Circulation 131:488-94. 2015
  2. pmc Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial
    Benjamin A Steinberg
    Duke Clinical Research Institute, PO Box 17969, NC 27715 Durham, NC, USA
    Eur Heart J 36:288-96. 2015
  3. pmc Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease
    Benjamin A Steinberg
    Duke Center for Atrial Fibrillation, Durham, NC, USA Department of Medicine, Duke University Medical Center, Durham, NC, USA Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC 27715, USA
    Europace 16:1284-90. 2014
  4. pmc Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
    Benjamin A Steinberg
    From the Duke University Medical Center, Durham, NC B A S, J P P, E D P Duke Clinical Research Institute, Durham, NC B A S, S K, L T, J P P, E D P UCLA School of Medicine, Los Angeles, CA G C F Boston University School of Medicine, Boston, MA E H New York University School of Medicine, Lenox Hill Hospital, New York, NY J A Kaiser Permanente, Oakland, CA A S G Janssen Pharmaceuticals, Inc, Raritan, NJ P C Lankenau Institute for Medical Research, Wynnewood, PA P K Mayo Clinic, Rochester, MN B J G Stanford University School of Medicine, Palo Alto, CA K W M and Harvard Medical School and Massachusetts General Hospital, Boston, MA D E S
    Circulation 129:2005-12. 2014
  5. pmc Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
    Benjamin A Steinberg
    Duke University Medical Center, Durham, NC Duke Clinical Research Institute, Durham, NC Electronic address
    Am Heart J 167:735-42.e2. 2014
  6. doi request reprint Structure-function relationships of factor Xa inhibitors: implications for the practicing clinician
    Benjamin A Steinberg
    Duke University Medical Center, PO Box 17969, Durham, NC, 27715, USA
    J Thromb Thrombolysis 37:234-41. 2014
  7. doi request reprint Cardiac conduction system disease after transcatheter aortic valve replacement
    Benjamin A Steinberg
    Division of Cardiology, Department of Medicine, DukeUniversity Hospital, Durham, NC 27705, USA
    Am Heart J 164:664-71. 2012
  8. pmc Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
    Benjamin A Steinberg
    Duke University Medical Center, Durham, NC 27715, USA
    Am Heart J 165:622-9. 2013
  9. doi request reprint Treatment pathways and quality improvement for patients with acute myocardial infarction at a tertiary care center
    Benjamin A Steinberg
    Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC 27705, USA
    Crit Pathw Cardiol 11:77-80. 2012
  10. pmc Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry
    Benjamin A Steinberg
    MPH, Duke University Medical Center and Duke Clinical Research Institute, 2400 Pratt St, Ste 7009, Durham, NC 27705, USA
    Circulation 128:721-8. 2013

Detail Information

Publications29

  1. pmc Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
    Benjamin A Steinberg
    From the Duke University Medical Center, Durham, NC B A S, E D P, M W S, J P P Duke Clinical Research Institute, Durham, NC B A S, E D P, S K, L T, M W S, J P P Mayo Clinic, Rochester, MN B J G UCLA Division of Cardiology, Los Angeles, CA G C F Lankenau Institute for Medical Research, Wynnewood, PA P R K Department of Medicine, Stanford University School of Medicine, Palo Alto, CA K W M Janssen Scientific Affairs, Raritan, NJ P C and New York University School of Medicine, Lenox Hill Hospital, New York, NY J A
    Circulation 131:488-94. 2015
    ..However, the use and outcomes of bridging during oral anticoagulation interruptions in clinical practice are unknown...
  2. pmc Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial
    Benjamin A Steinberg
    Duke Clinical Research Institute, PO Box 17969, NC 27715 Durham, NC, USA
    Eur Heart J 36:288-96. 2015
    ..Anticoagulation prophylaxis for stroke is recommended for at-risk patients with either persistent or paroxysmal atrial fibrillation (AF). We compared outcomes in patients with persistent vs. paroxysmal AF receiving oral anticoagulation...
  3. pmc Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease
    Benjamin A Steinberg
    Duke Center for Atrial Fibrillation, Durham, NC, USA Department of Medicine, Duke University Medical Center, Durham, NC, USA Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC 27715, USA
    Europace 16:1284-90. 2014
    ..Atrial fibrillation (AF) and coronary artery disease (CAD) are common in older patients. We aimed to describe the use of antiarrhythmic drug (AAD) therapy and clinical outcomes in these patients...
  4. pmc Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
    Benjamin A Steinberg
    From the Duke University Medical Center, Durham, NC B A S, J P P, E D P Duke Clinical Research Institute, Durham, NC B A S, S K, L T, J P P, E D P UCLA School of Medicine, Los Angeles, CA G C F Boston University School of Medicine, Boston, MA E H New York University School of Medicine, Lenox Hill Hospital, New York, NY J A Kaiser Permanente, Oakland, CA A S G Janssen Pharmaceuticals, Inc, Raritan, NJ P C Lankenau Institute for Medical Research, Wynnewood, PA P K Mayo Clinic, Rochester, MN B J G Stanford University School of Medicine, Palo Alto, CA K W M and Harvard Medical School and Massachusetts General Hospital, Boston, MA D E S
    Circulation 129:2005-12. 2014
    ..Although empirical models have been developed to predict such risks, the degree to which these coincide with clinicians' estimates is unclear...
  5. pmc Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
    Benjamin A Steinberg
    Duke University Medical Center, Durham, NC Duke Clinical Research Institute, Durham, NC Electronic address
    Am Heart J 167:735-42.e2. 2014
    ..Atrial fibrillation (AF) is the most common cardiac dysrhythmia and contributes significantly to health care expenditures. We sought to assess the frequency and predictors of hospitalization in patients with AF...
  6. doi request reprint Structure-function relationships of factor Xa inhibitors: implications for the practicing clinician
    Benjamin A Steinberg
    Duke University Medical Center, PO Box 17969, Durham, NC, 27715, USA
    J Thromb Thrombolysis 37:234-41. 2014
    ..The current review describes the development and pharmacokinetic properties of these agents, in the context of their clinical utility and pitfalls. ..
  7. doi request reprint Cardiac conduction system disease after transcatheter aortic valve replacement
    Benjamin A Steinberg
    Division of Cardiology, Department of Medicine, DukeUniversity Hospital, Durham, NC 27705, USA
    Am Heart J 164:664-71. 2012
    ....
  8. pmc Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
    Benjamin A Steinberg
    Duke University Medical Center, Durham, NC 27715, USA
    Am Heart J 165:622-9. 2013
    ..All patients with atrial fibrillation (AF) require optimization of their ventricular rate. Factors leading to use of additional rhythm control in clinical practice have not been thoroughly defined...
  9. doi request reprint Treatment pathways and quality improvement for patients with acute myocardial infarction at a tertiary care center
    Benjamin A Steinberg
    Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC 27705, USA
    Crit Pathw Cardiol 11:77-80. 2012
    ..There is also a structured process for review of cases and quality improvement, which incorporates physicians, administrators, and emergency medical personnel...
  10. pmc Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry
    Benjamin A Steinberg
    MPH, Duke University Medical Center and Duke Clinical Research Institute, 2400 Pratt St, Ste 7009, Durham, NC 27705, USA
    Circulation 128:721-8. 2013
    ..We assessed concomitant ASA use and its association with clinical outcomes among AF patients treated with OAC...
  11. pmc Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation
    Benjamin A Steinberg
    Duke University Medical Center, Durham, NC
    J Am Heart Assoc 2:e000535. 2013
    ..Dabigatran is a novel oral anticoagulant approved for thromboprophylaxis in atrial fibrillation. Adoption patterns of this new agent in community practice are unknown...
  12. pmc Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial
    Benjamin A Steinberg
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina Electronic address
    Heart Rhythm 11:925-32. 2014
    ..Antiarrhythmic drugs (AADs) and anticoagulation are mainstays of atrial fibrillation (AF) treatment...
  13. pmc Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry
    Benjamin A Steinberg
    Department of Medicine, Duke University Medical Center, Durham, North Carolina Duke Clinical Research Institute, Durham, North Carolina
    Clin Cardiol 37:7-13. 2014
    ..Postoperative atrial fibrillation (POAF) is a well-recognized complication of cardiac surgery; however, its management remains a challenge, and the implementation and outcomes of various strategies in clinical practice remain unclear...
  14. pmc Periprocedural imaging and outcomes after catheter ablation of atrial fibrillation
    Benjamin A Steinberg
    Duke Center for Atrial Fibrillation, Duke University Medical Center, Durham, North Carolina, USA Duke Clinical Research Institute, Durham, North Carolina, USA
    Heart 100:1871-7. 2014
    ..This has been partly attributed to the use of adjunctive imaging modalities. We aimed to describe the use and associated outcomes of periprocedural imaging for AF ablation...
  15. pmc Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry
    Benjamin A Steinberg
    Duke University Medical Center, Durham, NC Duke Clinical Research Institute, Durham, NC
    Am Heart J 168:160-7. 2014
    ..However, there are limited data on their use and outcomes in routine clinical practice, particularly among patients newly diagnosed as having AF and patients with AF recently transitioned to a NOAC...
  16. pmc Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies
    Benjamin A Steinberg
    Duke Center for Atrial Fibrillation, Electrophysiology Section, Duke University Medical Center, Durham, NC, USA
    J Interv Card Electrophysiol 37:213-21. 2013
    ..Dabigatran is approved for prevention of stroke or systemic embolism in patients with nonvalvular atrial fibrillation (AF). The safety and effectiveness of periprocedural dabigatran in ablation for AF are unknown...
  17. doi request reprint Anticoagulation in atrial fibrillation
    Benjamin A Steinberg
    Electrophysiology Section, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    BMJ 348:g2116. 2014
    ....
  18. doi request reprint Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes
    Benjamin A Steinberg
    Duke University Medical Center, Durham, NC, USA
    Circulation 126:65-75. 2012
    ..Heart failure with preserved ejection fraction (EF) is a common syndrome, but trends in treatments and outcomes are lacking...
  19. ncbi request reprint Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial
    Benjamin A Steinberg
    Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women s Hospital and Department of Medicine, Harvard Medical School, Boston, MA 02115, USA
    Am Heart J 154:54-61. 2007
    ..We hypothesized that adjustment for baseline risk would minimize such variations...
  20. doi request reprint Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgery
    Jonathan P Piccini
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina Electronic address
    Am J Cardiol 112:954-60. 2013
    ..In this high-risk population, we were unable to demonstrate that any of the commonly used preventive agents were associated with lower rates of AF compared with alternatives or no treatment. ..
  21. doi request reprint Evaluation and management of the atrial fibrillation patient: a report from the Society of Cardiovascular Patient Care
    Benjamin A Steinberg
    Duke University Medical Center, Durham, NC, USA
    Crit Pathw Cardiol 12:107-15. 2013
    ..This document presents the rationale, discussion, and supporting evidence for these criteria, in an effort to maximize effective and efficient AF care. ..
  22. doi request reprint Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease
    Jonathan P Piccini
    Duke Center for Atrial Fibrillation, Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina Electronic address
    Am J Cardiol 114:716-22. 2014
    ....
  23. ncbi request reprint Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry)
    Benjamin A Steinberg
    Thrombolysis in Myocardial Infarction TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 99:1212-5. 2007
    ..In conclusion, use of evidence-based, guideline-recommended therapies in outpatients with CAD needs to improve, especially in medically managed patients...
  24. pmc Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012
    Paul L Hess
    Duke Clinical Research Institute, Durham, NC Electronic address
    Am Heart J 168:239-247.e1. 2014
    ....
  25. ncbi request reprint Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: safety, tolerability, and therapeutic potential
    Benjamin A Steinberg
    Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland, USA
    Am J Cardiol 100:27P-32P. 2007
    ..When rimonabant becomes clinically available, physicians should be vigilant regarding the expected side effects and use alternative therapies if needed...
  26. pmc Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials
    Benjamin A Steinberg
    Department of Medicine, Duke University Medical Center, Durham, North Carolina Duke Clinical Research Institute, Duke University, Durham, North Carolina
    JACC Heart Fail 2:623-9. 2014
    ..The aim of this study was to determine if the benefit of implantable cardioverter-defibrillators (ICDs) is modulated by medical comorbidity...
  27. pmc Cost analysis of periprocedural imaging in patients undergoing catheter ablation for atrial fibrillation
    Sean D Pokorney
    Duke Center for Atrial Fibrillation, Division of Cardiology, Duke University Medical Center, Durham, North Carolina Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina
    Am J Cardiol 114:266-71. 2014
    ..The expenditures for periprocedural imaging vary both at the patient and at the provider level and they are inversely related to stroke risk by CHADS2 score...
  28. ncbi request reprint Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy
    Christopher P Cannon
    Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 48:438-45. 2006
    ..The purpose of this study was to conduct a meta-analysis that compares the reduction of cardiovascular outcomes with high-dose statin therapy versus standard dosing...
  29. ncbi request reprint Safety of bivalirudin during percutaneous coronary interventions in patients with abnormal renal function
    Ariel Roguin
    Department of Medicine, Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Int J Cardiovasc Intervent 7:88-92. 2005
    ..We aimed to test the safety of bivalirudin in routine practice and to assess whether this benefit was influenced by renal function...